SCHEMBL7422929

SCHEMBL7422929

CCOC(=O)CSc1ccccc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.56
ALDH1A1 P00352 3/20 0.53
HSD17B10 Q99714 3/20 0.53
KDM4E B2RXH2 2/20 0.53
HTT P42858 2/20 0.53
TP53 P04637 1/20 0.53
HPGD P15428 1/20 0.53
LMNA P02545 3/20 0.52
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
DHFR P00374 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
PRNP P04156 1/20 0.49
POLB P06746 3/20 0.48
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72974 0.88 HSD17B10 (0.50) GLAALDH1A1HSD17B10KDM4EHTT
SCHEMBL7423596 0.85 MTNR1A (0.56) GLAALDH1A1KDM4EHPGDLMNA
SCHEMBL7153877 0.82 L3MBTL1 (0.60) ALDH1A1HSD17B10KDM4EHTTTP53
SCHEMBL8870482 0.81 HSD17B10 (0.62) ALDH1A1HSD17B10KDM4EHTTTP53
SCHEMBL7419329 0.80 MTNR1A (0.56) ALDH1A1HSD17B10KDM4ELMNAMTNR1A
SCHEMBL806075 0.80 MTNR1A (0.60) ALDH1A1HSD17B10KDM4EHTTHPGD
SCHEMBL19403380 0.80 MTNR1A (0.50) GLAALDH1A1HSD17B10KDM4EHTT
SCHEMBL18301097 0.79 ALDH1A1 (0.55) ALDH1A1HSD17B10KDM4EHTTTP53
SCHEMBL28473859 0.79 ALDH1A1 (0.55) ALDH1A1HSD17B10KDM4EHTTTP53
SCHEMBL7617296 0.79 MAPT (0.50) ALDH1A1HSD17B10KDM4EHTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080768-A USEFUL IN THE TREATMENT OF ARTERIAL HYPERTENSION AND HEART FAILURE, RENAL INSUFFICIENCY, PERIPHERAL ARTERIOPATHIES AND CEREBROVASCULAR INSUFFICIENCIES ZAMBON GROUP S.P.A. (IT) 2000-06-27 US disclosed
US-5747513-A HYPOTENSIVE AGENTS, HEART FAILURE AND CEREBROVASCULAR INSUFFICIENCY ZAMBON GROUP, S.P.A. (IT) 1998-05-05 US disclosed
EP-0719252-B1 DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE ACTIVE ON THE CARDIOVASCULAR SYSTEM ZAMBON SPA (IT) 1998-02-18 EP disclosed
WO-1995007885-A1 DERIVATIVES OF 2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE ACTIVE ON THE CARDIOVASCULAR SYSTEM ZAMBON GROUP S.P.A. (IT) 1995-03-23 WO disclosed